Page last updated: 2024-09-04

rhodioloside and Brain Injuries

rhodioloside has been researched along with Brain Injuries in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Bai, J; Hou, Y; Jiang, S; Meng, X; Tang, Y; Wang, X; Xie, N; Zhang, Y1
Cairang, N; Chen, K; Fan, F; Jiang, S; Meng, X; Sun, Z; Wang, X; Yang, L; Zhang, Y1
Cui, Q; Ding, X; Lin, G; Sang, N; Tan, J; Wang, F; Xu, J; Xu, W; You, S; Zhan, C; Zhang, J; Zhang, P; Zhu, Y1
Brown, J; Chen, L; Chu, K; Hong, G; Lai, W; Xu, L; Ying, X; Zhang, X1
Chen, CC; Chen, SF; Hung, TH; Lee, CY; Liao, NC; Tsai, HJ; Wang, PY; Wu, CH1

Other Studies

5 other study(ies) available for rhodioloside and Brain Injuries

ArticleYear
Salidroside, a phenyl ethanol glycoside from Rhodiola crenulata, orchestrates hypoxic mitochondrial dynamics homeostasis by stimulating Sirt1/p53/Drp1 signaling.
    Journal of ethnopharmacology, 2022, Jul-15, Volume: 293

    Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Brain Injuries; Glucosides; Glycosides; Homeostasis; Hypoxia; Mitochondrial Dynamics; Molecular Docking Simulation; Phenols; Phenylethyl Alcohol; Rhodiola; Signal Transduction; Sirtuin 1; Superoxide Dismutase; Tumor Suppressor Protein p53

2022
Salidroside attenuates high altitude hypobaric hypoxia-induced brain injury in mice via inhibiting NF-κB/NLRP3 pathway.
    European journal of pharmacology, 2022, Jun-15, Volume: 925

    Topics: Adenosine Triphosphatases; Altitude; Animals; Brain Injuries; Glucosides; Hypoxia; Mice; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Phenols

2022
Multi-pathway neuroprotective effects of a novel salidroside derivative SHPL-49 against acute cerebral ischemic injury.
    European journal of pharmacology, 2023, Jun-15, Volume: 949

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Brain Injuries; Brain Ischemia; Calcium; Infarction, Middle Cerebral Artery; Ischemia; Neuroprotective Agents; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Reperfusion Injury

2023
Salidroside Reduces Inflammation and Brain Injury After Permanent Middle Cerebral Artery Occlusion in Rats by Regulating PI3K/PKB/Nrf2/NFκB Signaling Rather than Complement C3 Activity.
    Inflammation, 2019, Volume: 42, Issue:5

    Topics: Animals; Brain Injuries; Brain Ischemia; Complement C3; Glucosides; Infarction, Middle Cerebral Artery; Inflammation; Neuroprotection; NF-E2-Related Factor 2; Phenols; Phosphatidylinositol 3-Kinases; Rats; Signal Transduction

2019
Salidroside improves behavioral and histological outcomes and reduces apoptosis via PI3K/Akt signaling after experimental traumatic brain injury.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Antioxidants; Apoptosis; Brain Edema; Brain Injuries; Cells, Cultured; Cerebral Cortex; Chromones; Dose-Response Relationship, Drug; Glucosides; Hippocampus; Injections, Intraperitoneal; Mitochondria; Morpholines; Motor Activity; Neurons; Neuroprotective Agents; Organ Specificity; Phenols; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rotarod Performance Test; Signal Transduction; Stress, Physiological

2012